SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Maya Tanase, Valerio Zolla, Cristina C Clement, Francesco Borghi, Aleksandra M Urbanska, Jose Antonio Rodriguez-Navarro, Barbara Roda, Andrea Zattoni, Pierluigi Reschiglian, Ana Maria Cuervo, Laura Santambrogio, Hydrodynamic size-based separation and characterization of protein aggregates from total cell lysates, Nature Protocols, 2014, 10, 1, 134

    CrossRef

  2. 2
    Tiziana Alberio, Heather Bondi, Flavia Colombo, Isabella Alloggio, Luisa Pieroni, Andrea Urbani, Mauro Fasano, Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis, Molecular BioSystems, 2014, 10, 6, 1332

    CrossRef

  3. 3
    N. Casadei, A.-M. Pohler, C. Tomas-Zapico, J. Torres-Peraza, I. Schwedhelm, A. Witz, I. Zamolo, R. De Heer, B. Spruijt, L. P. J. J. Noldus, J. Klucken, J. J. Lucas, P. J. Kahle, R. Kruger, O. Riess, S. Nuber, Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice, Human Molecular Genetics, 2014, 23, 3, 767

    CrossRef

  4. 4
    Min Xie, Ruihong Shi, Ying Pan, Tao Zeng, Qicai Chen, Shaohui Wang, Xiaomei Liao, Proteasome Inhibition-Induced Downregulation of Akt/GSK-3β Pathway Contributes to Abnormality of Tau in Hippocampal Slice, Molecular Neurobiology, 2014, 50, 3, 888

    CrossRef

  5. 5
    Eleni N. Tsakiri, Ioannis P. Trougakos, 2014,

    CrossRef

  6. 6
    Scott Brady, David R. Colman, Peter Brophy, From Molecules to Networks, 2014,

    CrossRef

  7. 7
    Maria Xilouri, Oystein Rod Brekk, Leonidas Stefanis, Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship, Molecular Neurobiology, 2013, 47, 2, 537

    CrossRef

  8. 8
    Alison L. Müller, Larry V. Hryshko, Naranjan S. Dhalla, Extracellular and intracellular proteases in cardiac dysfunction due to ischemia–reperfusion injury, International Journal of Cardiology, 2013, 164, 1, 39

    CrossRef

  9. 9
    Leonardo Bonilla-Ramirez, Marlene Jimenez-Del-Rio, Carlos Velez-Pardo, Low doses of paraquat and polyphenols prolong life span and locomotor activity in knock-down parkin Drosophila melanogaster exposed to oxidative stress stimuli: Implication in autosomal recessive juvenile Parkinsonism, Gene, 2013, 512, 2, 355

    CrossRef

  10. 10
    Aikaterini Argyropoulou, Nektarios Aligiannis, Ioannis P. Trougakos, Alexios-Leandros Skaltsounis, Natural compounds with anti-ageing activity, Natural Product Reports, 2013, 30, 11, 1412

    CrossRef

  11. 11
    Fabio Blandini, Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease, Journal of Neuroimmune Pharmacology, 2013, 8, 1, 189

    CrossRef

  12. 12
    Sara Sepe, Cesar Payan-Gomez, Chiara Milanese, Jan H. Hoeijmakers, Pier G. Mastroberardino, Nucleotide excision repair in chronic neurodegenerative diseases, DNA Repair, 2013, 12, 8, 568

    CrossRef

  13. 13
    Abdullah Shafique Ahmad, Takayuki Maruyama, Shuh Narumiya, Sylvain Doré, PGE2 EP1 Receptor Deletion Attenuates 6-OHDA-Induced Parkinsonism in Mice: Old Switch, New Target, Neurotoxicity Research, 2013, 23, 3, 260

    CrossRef

  14. 14
    Katrin Eckermann, SUMO and Parkinson’s Disease, NeuroMolecular Medicine, 2013, 15, 4, 737

    CrossRef

  15. 15
    Lamia'a Bahnassawy, Sarah Nicklas, Thomas Palm, Ingeborg Menzl, Fabian Birzele, Frank Gillardon, Jens C. Schwamborn, The Parkinson's Disease-Associated LRRK2 Mutation R1441G Inhibits Neuronal Differentiation of Neural Stem Cells, Stem Cells and Development, 2013, 22, 18, 2487

    CrossRef

  16. 16
    Ulrike Krüger, Yipeng Wang, Satish Kumar, Eva-Maria Mandelkow, Autophagic degradation of tau in primary neurons and its enhancement by trehalose, Neurobiology of Aging, 2012, 33, 10, 2291

    CrossRef

  17. 17
    Till Wenger, Seigo Terawaki, Voahirana Camosseto, Ronza Abdelrassoul, Anna Mies, Nadia Catalan, Nuno Claudio, Giovanna Clavarino, Aude de Gassart, Francesca de Angelis Rigotti, Evelina Gatti, Philippe Pierre, Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation, Autophagy, 2012, 8, 3, 350

    CrossRef

  18. 18
    Tiziana Alberio, Leonardo Lopiano, Mauro Fasano, Cellular models to investigate biochemical pathways in Parkinson’s disease, FEBS Journal, 2012, 279, 7
  19. 19
    Laura Berliocchi, Rossella Russo, Cristina Tassorelli, Luigi Antonio Morrone, Giacinto Bagetta, Maria Tiziana Corasaniti, Death in pain: peripheral nerve injury and spinal neurodegenerative mechanisms, Current Opinion in Pharmacology, 2012, 12, 1, 49

    CrossRef

  20. 20
    Matthew E. Gegg, Derek Burke, Simon J. R. Heales, J. Mark Cooper, John Hardy, Nicholas W. Wood, Anthony H. V. Schapira, Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains, Annals of Neurology, 2012, 72, 3
  21. 21
    Martin Stöckl, Mireille M. A. E. Claessens, Vinod Subramaniam, Kinetic measurements give new insights into lipid membrane permeabilization by α-synuclein oligomers, Molecular BioSystems, 2012, 8, 1, 338

    CrossRef

  22. 22
    Catherine Terret, Florence Solari, L’homéostasie métabolique au cœur du vieillissement, médecine/sciences, 2012, 28, 3, 311

    CrossRef

  23. 23
    M. Maral Mouradian, MicroRNAs in Parkinson's disease, Neurobiology of Disease, 2012, 46, 2, 279

    CrossRef

  24. 24
    S.M. Cardoso, A.R. Esteves, D.M. Arduíno, Mitochondrial Metabolic Control of Microtubule Dynamics Impairs the Autophagic Pathway in Parkinson’s Disease, Neurodegenerative Diseases, 2012, 10, 1-4, 38

    CrossRef

  25. 25
    M. Sharma, J. Burre, T. C. Sudhof, Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration, Science Translational Medicine, 2012, 4, 147, 147ra113

    CrossRef

  26. 26
    Salvatore Condello, Emanuele Calabrò, Daniela Caccamo, Monica Currò, Nadia Ferlazzo, Joseph Satriano, Salvatore Magazù, Riccardo Ientile, Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson’s disease, Amino Acids, 2012, 42, 2-3, 775

    CrossRef

  27. 27
    Gustavo M. Silva, Luis E.S. Netto, Vanessa Simões, Luiz F.A. Santos, Fabio C. Gozzo, Marcos A.A. Demasi, Cristiano L.P. Oliveira, Renata N. Bicev, Clécio F. Klitzke, Mari C. Sogayar, Marilene Demasi, Redox Control of 20S Proteasome Gating, Antioxidants & Redox Signaling, 2012, 16, 11, 1183

    CrossRef

  28. 28
    Alison L. Müller, Naranjan S. Dhalla, Role of various proteases in cardiac remodeling and progression of heart failure, Heart Failure Reviews, 2012, 17, 3, 395

    CrossRef

  29. 29
    Mi Jin Kim, Dae Won Kim, Hoon Jae Jeong, Eun Jeong Sohn, Min Jea Shin, Eun Hee Ahn, Soon Won Kwon, Young Nam Kim, Duk-Soo Kim, Jinseu Park, Won Sik Eum, Hyun Sook Hwang, Soo Young Choi, Tat-Frataxin protects dopaminergic neuronal cells against MPTP-induced toxicity in a mouse model of Parkinson's disease, Biochimie, 2012, 94, 11, 2448

    CrossRef

  30. 30
    Sermin Genc, Zeynep Zadeoglulari, Stefan H. Fuss, Kursad Genc, The Adverse Effects of Air Pollution on the Nervous System, Journal of Toxicology, 2012, 2012, 1

    CrossRef

  31. 31
    Kurt A. Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2, 75

    CrossRef

  32. 32
    B. N. Johnson, A. K. Berger, G. P. Cortese, M. J. LaVoie, The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax, Proceedings of the National Academy of Sciences, 2012, 109, 16, 6283

    CrossRef

  33. 33
    Aditiben Patel, Giuseppe V. Toia, Kalea Colletta, Brinda Desai Bradaric, Paul M. Carvey, Bill Hendey, An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity, Experimental Neurology, 2011, 231, 1, 160

    CrossRef

  34. 34
    Fernando Calahorro, Manuel Ruiz-Rubio, Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson’s disease, Alzheimer’s disease and autism spectrum disorder, Invertebrate Neuroscience, 2011, 11, 2, 73

    CrossRef

  35. 35
    Judith Eschbach, Luc Dupuis, Cytoplasmic dynein in neurodegeneration, Pharmacology & Therapeutics, 2011, 130, 3, 348

    CrossRef

  36. 36
    Aabgeena Naeem, Naveed Ahmad Fazili, Defective Protein Folding and Aggregation as the Basis of Neurodegenerative Diseases: The Darker Aspect of Proteins, Cell Biochemistry and Biophysics, 2011, 61, 2, 237

    CrossRef

  37. 37
    Janusz Lipski, Robert Nistico, Nicola Berretta, Ezia Guatteo, Giorgio Bernardi, Nicola B. Mercuri, l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?, Progress in Neurobiology, 2011, 94, 4, 389

    CrossRef

  38. 38
    Maria Trinidad Herrero, Javier Pagonabarraga, Gurutz Linazasoro, Neuroprotective Role of Dopamine Agonists, The Neurologist, 2011, 17, S54

    CrossRef

  39. 39
    Y. Li, O.W. Wan, W. Xie, K.K.K. Chung, p32 regulates mitochondrial morphology and dynamics through parkin, Neuroscience, 2011, 199, 346

    CrossRef

  40. 40
    Kostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, Hardy J Rideout, Leonidas Stefanis, Pathological roles of α-synuclein in neurological disorders, The Lancet Neurology, 2011, 10, 11, 1015

    CrossRef

  41. 41
    Tiziana Alberio, Mauro Fasano, Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies, Journal of Biotechnology, 2011, 156, 4, 325

    CrossRef

  42. 42
    Valerie Askanas, W. King Engel, Sporadic inclusion-body myositis: Conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau, La Presse Médicale, 2011, 40, 4, e219

    CrossRef

  43. 43
    J. L. Cummings, C. Henchcliffe, S. Schaier, T. Simuni, A. Waxman, P. Kemp, The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration, Brain, 2011, 134, 11, 3146

    CrossRef

  44. 44
    Ryan P. McGlinchey, Thai Leong Yap, Jennifer C. Lee, The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17, Physical Chemistry Chemical Physics, 2011, 13, 45, 20066

    CrossRef

  45. 45
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  46. 46
    David Sulzer, Clues to how alpha-synuclein damages neurons in Parkinson's disease, Movement Disorders, 2010, 25, S1
  47. 47
    M. E. Gegg, J. M. Cooper, K.-Y. Chau, M. Rojo, A. H. V. Schapira, J.-W. Taanman, Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy, Human Molecular Genetics, 2010, 19, 24, 4861

    CrossRef

  48. 48
    Shuchi Mittal, Subramaniam Ganesh, Protein quality control mechanisms and neurodegenerative disorders: Checks, balances and deadlocks, Neuroscience Research, 2010, 68, 3, 159

    CrossRef

  49. 49
    Marcia C. Haigis, Bruce A. Yankner, The Aging Stress Response, Molecular Cell, 2010, 40, 2, 333

    CrossRef

  50. 50
    Gregory R. Adams, Marcas M. Bamman, Characterization and Regulation of Mechanical Loading-Induced Compensatory Muscle Hypertrophy, Comprehensive Physiology,
  51. 51
    Maria Grazia Spillantini, Introduction to α-Synucleinopathies,
  52. 52
    Susana Gonçalves, Hugo Vicente Miranda, Tiago F. Outeiro, Novel Molecular Therapeutics in Parkinson's Disease,
  53. 53
    Kurt A. Jellinger, Parkinson's Disease,
  54. 54
    Valerie Askanas, W. King Engel, Anna Nogalska, Pathogenesis of Sporadic Inclusion-Body Myositis: Role of Aging and Muscle-Fiber Degeneration, and Accumulation of the Same Proteins as in Alzheimer and Parkinson Brains,
  55. 55
    Martin Stöckl, Bart D. van Rooijen, Mireille M. A. E. Claessens, Vinod Subramaniam, Structural and Functional Insights into α-Synuclein–Lipid Interactions,